Mike J. Mason

Community assessment to advance computational prediction of cancer drug combinations in a pharmacogenomic screen

Michael P. Menden, Dennis Wang, Mike J. Mason et al. · Nature Communications · 2019 · 363 citations · Full text

Medicine, Oncology, Pharmacology +16

Relative contribution of clinicopathological variables, genomic markers, transcriptomic subtyping and microenvironment features for outcome prediction in stage II/III colorectal cancer

Rodrigo Dienstmann, Guillermo Villacampa, Anita Sveen et al. · Annals of Oncology · 2019 · 266 citations · Full text

Medicine, Biostatistics, Oncology +17

Prediction of overall survival in stage II and III colon cancer beyond TNM system: a retrospective, pooled biomarker study

Rodrigo Dienstmann, Mike J. Mason, Frank A. Sinicrope et al. · Annals of Oncology · 2017 · 253 citations · Full text

Medicine, Biostatistics, Oncology +17

Coupling between intracellular Ca2+ stores and the Ca2+ permeability of the plasma membrane. Comparison of the effects of thapsigargin, 2,5-di-(tert-butyl)-1,4-hydroquinone, and cyclopiazonic acid in rat thymic lymphocytes.

Mike J. Mason, Carmen García‐Rodríguez, Sergio Grinstein · Journal of Biological Chemistry · 1991 · 238 citations · Full text

Life Sciences, Biochemistry, Pharmacology +14

Inhibition of Ca2+ transport pathways in thymic lymphocytes by econazole, miconazole, and SKF 96365

Mike J. Mason, Bernd Mayer, Lin Hymel · American Journal of Physiology-Cell Physiology · 1993 · 131 citations

Life Sciences, Cell Biology, Pharmacology +17